Log in with your email address username.

×

[Comment] Reducing harm in the treatment of multidrug-resistant tuberculosis

When describing the profound hearing loss she suffered as a result of her treatment for multidrug-resistant tuberculosis, the noted advocate Nandita Venkatesan said: “My world fell silent around me. I am in front of people, but I am not here.”1 In the context of India’s National Tuberculosis Programme, she seems to be right: 8 years after she was clinically diagnosed, first with abdominal tuberculosis and then multidrug-resistant tuberculosis, Venkatesan was declared to be a treatment success. This outcome is a rarity in multidrug-resistant tuberculosis, for which global success rates are roughly 50%.

email